Ying Luo's most recent trade in Gyre Therapeutics Inc was a trade of 120,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gyre Therapeutics Inc | Ying Luo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2026 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Ying Luo | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.04 per share. | 05 May 2026 | 10,136 | 2,565,226 | - | 8.0 | 81,493 | Common Stock |
| Gyre Therapeutics Inc | Ying Luo | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 05 May 2026 | 179 | 2,575,362 | - | 8.0 | 1,434 | Common Stock |